hip fracture
Conditions
Interventions
Group P:Group P: The patient lies in a supine position. The skin is disinfected. A portable ultrasound device is used, and a low-frequency curve ultrasound transducer is coated with ultrasound couplin
Group C:Administrer aux patients 50mg de flubiprofénate intraveineux sous pression statique toute
Sponsors
The 960th Hospital of the Joint Support Force of the People's Liberation Army of China
Eligibility
Sex/Gender
All
Age
65 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Hip fracture surgery needs to be scheduled for a later date; 2. Age: 65 years old to 85 years old; 3. BMI: 18 - 30 kg/m^2; 4. Normal coagulation function; 5. ASA: Grade II to III.
Exclusion criteria
Exclusion criteria: 1. Patients who have had allergic reactions to the drugs used in this trial; 2. Patients with local or systemic infections; 3. Patients with coagulation disorders; 4. Patients with severe cardiac or pulmonary dysfunction; 5. Patients with a history of hip joint surgery on the same side; 6. Psychiatric patients; those with language, communication or hearing impairments; 7. Patients who refuse to participate in this trial; 8. Patients with multiple systemic injuries.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of pain;The frequency, dosage and adverse reactions of post-admission and pre-operative analgesic drug supplementation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Stress level;The patient's satisfaction score for the analgesic effect;sleep quality; | — |
Countries
China
Contacts
Public ContactLiu Na
The 960th Hospital of the Joint Support Force of the People's Liberation Army of China
Outcome results
None listed